Latest News
Alternative lender Growth Street has revealed that 37.4 per cent of its investors are under the age of 35, contradicting public figures who have chastised millennials for not thinking about saving and investment.
Growth Street’s news follows comments made by property mogul Tim Gurner earlier this month. In an interview, Gurner asserted that spending too much on avocados has contributed to lower levels of homeownership among millennial consumers.
Last year, the FT asserted that “20-somethings feel financially doomed so do not save”.
Simple digital interfaces and investing products offered by alternative lenders like Growth Street are aimed
Crowdfunding platform, Seedrs, is to join other alternative finance firms as the sole equity finance provider in partnership with a new NatWest programme for British SMEs called Capital Connections.
Capital Connections offers NatWest’s business and commercial customers introductions via their relationship managers to a handful of alternative funding solutions available in the UK. The panel signposts business customers to innovative sources of finance including equity crowdfunding and marketplace lenders. There is no commission paid as a result of any referrals, ensuring maximum transparency and no conflict of interest.
NatWest has selected Seedrs as the only equity based finance provider due,
Panaseer, a cyber security data analytics company, has raised USD3.25 million in further funding from existing investors Albion Ventures, Notion Capital and Winton Ventures and new investors Paladin Capital Group and Evolution Equity Partners.
The new raise brings total investment into Panaseer to USD5.6 million.
Panaseer offers a big data analytics software platform designed to automate identification, measurement, communication, and mitigation of cyber risk. The Panaseer Security Data Lake gives data-driven CISOs the continuous visibility and automated reporting capability they need to seamlessly optimise cyber hygiene across their environments and rapidly answer cyber risk questions from executives and
UK private equity house Maven Capital Partners has invested GBP1 million in ebb3, with the potential for an additional GBP0.5 million of follow-on funding.
ebb3 is a technology services business operating in a niche part of the high performance computing market. It delivers data intensive 3D graphical applications to customers on any device using High Performance Virtual Computers (HPVCs) and its solutions negate the need for businesses to maintain and run traditional fixed location computer workstations across their organisations.
ebb3’s technology is able to drive heavyweight applications for the likes of computer assisted design (CAD) or computer generated
ViraTherapeutics, a biopharmaceutical company developing virus-based immunotherapeutics, which is backed by Boehringer Ingelheim Venture Fund (BIVF), has appointed Dr Heinz Schwer as CEO.
He takes over the position from interim CEO and co-founder Professor Dr Dorothee von Laer, who will remain a scientific adviser.
Schwer is a biotech executive with strong experience in strategic leadership, business development, M&A and drug development.
Prior to joining ViraTherapeutics, Schwer served as CEO of Lanthio Pharma at the time the company was acquired by MorphoSys. He was previously founder and CEO of Sloning BioTechnology, which was sold to MorphoSys, where he
AB Tasty has secured a USD17 million Series B investment from Korelya Capital and Partech Ventures, with participation from previous investors Xange Private Equity and Omnes Capital.
AB Tasty will use this round of funding to extend its leadership position in conversion rate optimization and accelerate its commercial development in the US, where the company will focus on expanding its current portfolio of clients such as Sephora, Mercedez-Benz, Groupon and Pizza Hut.
“We have had triple digit growth rates in Europe for the past consecutive six years and have built a substantial portfolio of customers,” says Alix de
Peapack-Gladstone Financial Corporation, parent company of Peapack-Gladstone Bank, is to acquire New Jersey-based Murphy Capital Management (MCM).
After up front transaction costs, the purchase will be immediately accretive to earnings.
Doug Kennedy, president and chief executive officer of Peapack-Gladstone Bank, says: “We have found what we feel is the perfect match with MCM and are thrilled this leader in the wealth management space, that shares our geography, will partner with us by joining our private wealth management team.”
Founded in 1983 by John J. Murphy, MCM adheres to a sophisticated and objective method to creating wealth and
Private equity firm Irving Place Capital (IPC) has agreed to sell thermal technology company Chromalox to Spirax-Sarco Engineering, a UK-based company specialising in the control and efficient use of steam and other industrial fluids, for USD415 million in cash.
Completion of the transaction is subject to customary closing conditions.
Chromalox is a technology company that delivers temperature management and process heating solutions for customers in a diverse range of industrial markets.
Chromalox was founded in 1917 and is headquartered in Pittsburgh, PA. IPC acquired Chromalox in December 2012.
“It has been a pleasure to work with
Free Form Factory, a designer and builder of electric watercraft, has closed its latest seed funding round, raising USD500,000 from a group of investors.
It is preparing for a Series A funding round of USD3.5 million.
“With the announcement of our electric-powered Gratis X1, we are moving quickly to deliver to the market a watercraft that has disrupted the traditional thinking within the personal watercraft space.” says founder and CEO of Free Form Factory Jordan Darling.
“Our initial investors have allowed Free Form Factory to design, develop, and launch an exhilarating electric personal watercraft that will soon
Bluebee, a provider of high-performance genomics analysis and storage solutions, and MediSapiens, a biomedical big data curation, management and interpretation company, have formed a partnership to provide customers with analytical solutions for next generation sequencing data.
Sequencing technology is maturing and being optimised for performance, while becoming increasingly affordable. This has opened an era of reliable and foreseeable quality data growth, which demands high computational resources and data storage capabilities to be combined with best in class data interpretation tools.
MediSapiens’ Explorer Platform is now integrated with the Bluebee platform, offering researchers and clinicians the ability to efficiently
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
